India's Hikal falls after US FDA issues warning letter for Jigani facility

Hikal

22/08/2025 05:04

** Shares of pharmaceutical company Hikal HIKA.NS fall 2.2% to 248 rupees, on track for its third straight session of losses

** Co receives warning letter from US FDA for it's manufacturing facility in Jigani, Bengaluru

** US FDA inspected the facility from Feb 3- Feb 7

** Co did not specify what the warning was for

** Co says committed to resolve issue at the earliest

** Stock down 36% YTD

 (Reporting by Komal Salecha)

 ((Komal@thomsonreuters.com;))